Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts. - Martufi M; Good RB; Rapiteanu R; Schmidt T; Patili E; Tvermosegaard K; New M; Nanthakumar CB; Betts J; Blanchard AD; Maratou K (The CRISPR journal, 2019)